Related Experiment Video
Updated: Oct 31, 2025
10:03
Characterization of Electrode Materials for Lithium Ion and Sodium Ion Batteries Using Synchrotron Radiation Techniques
Published on: November 11, 2013
25.7K
Lithium orotate: A superior option for lithium therapy?
Anthony G Pacholko1, Lane K Bekar1
1Department of Anatomy, Physiology and Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Brain and Behavior
|July 1, 2021
Summary
Lithium orotate may offer a safer alternative to lithium carbonate for bipolar disorder treatment. This review explores its efficacy, mechanisms, and potential to reduce adverse effects.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Bipolar disorder (BD) is a serious mental health condition with high suicide rates.
- Lithium carbonate is a common treatment but has significant adverse effects.
- These side effects can reduce patient adherence and treatment effectiveness.
Purpose of the Study:
- To review the controversial history and therapeutic potential of lithium orotate (LiOr) as an alternative to lithium carbonate for bipolar disorder.
- To evaluate experimental and clinical evidence regarding LiOr's efficacy and safety profile.
- To discuss the proposed mechanisms of action and potential future applications of LiOr in BD therapy.
Main Methods:
- Literature review of historical and contemporary studies on lithium orotate.
- Analysis of experimental data and clinical trials concerning LiOr's efficacy and toxicity.
- Examination of proposed pharmacological mechanisms and adverse event profiles.
Main Results:
- Lithium orotate is hypothesized to cross the blood-brain barrier more effectively than lithium carbonate.
- This improved transport may allow for lower therapeutic doses and reduced toxicity.
- Evidence on LiOr's efficacy and safety remains controversial and requires further investigation.
Conclusions:
- Lithium orotate presents a potential alternative to lithium carbonate for bipolar disorder management.
- Further research is needed to clarify its therapeutic benefits and safety profile.
- LiOr's unique properties may offer improved treatment outcomes with fewer adverse effects.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
389
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
389
01:30Electroconvulsive Therapy
317
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
317
01:28Drug Therapy
131
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
131
01:26Psychosis: Goals of Pharmacotherapy
290
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
290
01:23Antidepressant Drugs: MAOIs and Other Agents
517
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
517
01:19Management of Insomnia
361
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
361